How has been the historical performance of Dr Reddy's Labs?

Answer:The historical performance of Dr Reddy's Labs shows a consistent growth trajectory in net sales and profitability over the years.

Breakdown:
Dr Reddy's Labs has demonstrated significant growth in net sales, increasing from 15,448.20 Cr in Mar'19 to 32,643.90 Cr in Mar'25. This upward trend is reflected in total operating income, which also rose from 15,448.20 Cr in Mar'19 to 32,643.90 Cr in Mar'25. The company's operating profit (PBDIT) has similarly improved, reaching 9,644.40 Cr in Mar'25 from 3,515.70 Cr in Mar'19. Profit before tax has increased from 2,292.00 Cr in Mar'19 to 7,657.80 Cr in Mar'25, while profit after tax has grown from 1,906.20 Cr to 5,703.50 Cr over the same period. The company's total assets have expanded from 22,005.40 Cr in Mar'20 to 47,594.10 Cr in Mar'25, indicating robust asset growth. Total liabilities have also increased, rising from 22,005.40 Cr in Mar'20 to 47,594.10 Cr in Mar'25, reflecting the company's expansion strategy. Cash flow from operating activities has shown variability, with a notable increase to 4,642.00 Cr in Mar'25, while cash flow from investing activities has been negative, indicating ongoing investments in growth. Overall, Dr Reddy's Labs has shown strong financial performance with increasing revenues and profits, alongside significant investments in its future.